nisoxetine has been researched along with oxidopamine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tejani-Butt, SM | 1 |
Goldberg, SR; Schindler, CW; Tella, SR | 1 |
Barrier, L; Chalon, S; Huguet, F; Page, G; Piriou, A | 1 |
Cheetham, S; Jenner, P; Lane, EL | 1 |
Barrera, G; Drolet, G; Hernandez, A; Laforest, S; Morilak, DA; Poulin, JF | 1 |
Babankova, D; Habecker, BA; Kreulen, DL; Novotny, M; Parker, LM; Spitsbergen, JM; Swain, GM; Wehrwein, EA; Wright, AA | 1 |
6 other study(ies) available for nisoxetine and oxidopamine
Article | Year |
---|---|
[3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
Topics: 5,7-Dihydroxytryptamine; Animals; Autoradiography; Binding, Competitive; Brain; Cerebral Cortex; Fluoxetine; Kinetics; Male; Maprotiline; Norepinephrine; Oxidopamine; Radioligand Assay; Rats; Rats, Inbred Strains; Stereoisomerism; Tritium | 1992 |
Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system.
Topics: Adrenal Medulla; Animals; Biological Transport; Blood Pressure; Catecholamines; Chlorisondamine; Cocaine; Desipramine; Fluoxetine; Heart Rate; Male; Norepinephrine; Oxidopamine; Peripheral Nervous System; Propanolamines; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Time Factors | 1993 |
Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; In Vitro Techniques; Male; Motor Activity; Norepinephrine; Nortropanes; Oxidopamine; Piperazines; Rats; Rats, Wistar; Reserpine; Selective Serotonin Reuptake Inhibitors; Tetrabenazine | 1998 |
Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors.
Topics: Animals; Chlorobenzenes; Cyclobutanes; Dopamine Uptake Inhibitors; Fluoxetine; Male; Motor Activity; Norepinephrine; Oxidopamine; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Rotation | 2005 |
Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals.
Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Amygdala; Animals; Anti-Anxiety Agents; Autoradiography; Behavior, Animal; Cell Count; Cholera Toxin; Drug Interactions; Fluoxetine; Galanin; Gene Expression Regulation; Immunohistochemistry; In Situ Hybridization; Locus Coeruleus; Male; Maze Learning; Norepinephrine; Oncogene Proteins v-fos; Oxidopamine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Restraint, Physical; Septal Nuclei; Stilbamidines; Stress, Physiological; Tritium; Yohimbine | 2006 |
Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content.
Topics: Animals; Blotting, Western; Fluoxetine; Heart; Immunohistochemistry; Male; Myocardium; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Oxidopamine; Rats; Rats, Sprague-Dawley; Stellate Ganglion; Sympathectomy, Chemical; Sympatholytics; Tritium | 2008 |